These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7354448)

  • 1. Further considerations on model-independent bioavailability estimation.
    Hwang S; Kwan KC
    J Pharm Sci; 1980 Jan; 69(1):77-80. PubMed ID: 7354448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a novel method to estimate absolute bioavailability of drugs from oral data.
    Hinderling PH
    Biopharm Drug Dispos; 2003 Jan; 24(1):1-16. PubMed ID: 12516074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant.
    Collier PS; Riegelman S
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):205-14. PubMed ID: 6886975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion: does it accurately reflect relative differences in bioavailability/systemic exposure when renal clearance is nonlinear?
    Thompson GA; Toothaker RD
    Pharm Res; 2004 May; 21(5):781-4. PubMed ID: 15180334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approach to bioavailability testing: statistical method for comparing drug input calculated by a least-squares deconvolution technique.
    Pedersen PV
    J Pharm Sci; 1980 Mar; 69(3):318-24. PubMed ID: 7381709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for estimating within-individual variability in clearance and in volume of distribution from standard bioavailability studies.
    Upton RA; Thiercelin JF; Moore JK; Riegelman S
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):135-46. PubMed ID: 7120044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bioavailability and first-pass effects.
    Kwan KC
    Drug Metab Dispos; 1997 Dec; 25(12):1329-36. PubMed ID: 9394021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A liner mode of reversible metabolism and its application to bioavailability assessment.
    Hwang S; Kwan KC; Albert KS
    J Pharmacokinet Biopharm; 1981 Dec; 9(6):693-709. PubMed ID: 7341755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
    [No Abstract]   [Full Text] [Related]  

  • 11. Parameter estimation for the one compartment open model.
    McMillan I; Minder CE
    Comput Biomed Res; 1981 Jun; 14(3):232-9. PubMed ID: 7285552
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioavailability under variable renal clearance conditions.
    Oie S; Jung D
    J Pharm Sci; 1979 Jan; 68(1):128-9. PubMed ID: 758455
    [No Abstract]   [Full Text] [Related]  

  • 13. [Feasibility of the in vitro evaluation of bioavailability. 3: Method of operation of a newly-developed absorption model and results obtained with it].
    Fürst W; Neubert R; Stütz B; Fuchs G; Buchmann E
    Pharmazie; 1982 Aug; 37(8):571-7. PubMed ID: 7146065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability.
    Wagner JG
    Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.
    Smolen VF
    J Pharmacokinet Biopharm; 1976 Aug; 4(4):337-53. PubMed ID: 978396
    [No Abstract]   [Full Text] [Related]  

  • 18. Skin as an active metabolizing barrier I: Theoretical analysis of topical bioavailability.
    Ando HY; Ho NF; Higuchi WI
    J Pharm Sci; 1977 Nov; 66(11):1525-8. PubMed ID: 915724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of computers in pharmacokinetics.
    Danek A
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):345-50. PubMed ID: 689793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ; Smith TW; Koch-Weser J
    Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.